# FDA Inspection 1036380 - Regenerative Biologics, Inc. - November 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/13f91929-062d-4509-a1e8-746254a81a9b
Source feed: FDA_Inspections

> FDA Inspection 1036380 for Regenerative Biologics, Inc. on November 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036380
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2017-11-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/72477386-4717-4632-80fd-bd7e7e510faa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d